Publicaciones en las que colabora con MARIA ISABEL LOPEZ GALVEZ (108)

2023

  1. Comparación de múltiples redes neuronales convolucionales para el diagnóstico automático de la degeneración macular asociada a la edad usando retinografías

    CASEIB 2023. Libro de Actas del XLI Congreso Anual de la Sociedad Española de Ingeniería Biomédica: Contribuyendo a la salud basada en valor

  2. Un enfoque explicativo para el diagnóstico de la degeneración macular asociada a la edad mediante técnicas de deep learning

    CASEIB 2023. Libro de Actas del XLI Congreso Anual de la Sociedad Española de Ingeniería Biomédica: Contribuyendo a la salud basada en valor

2022

  1. A Screening Tool for Self-Evaluation of Risk for Age-Related Macular Degeneration: Validation in a Spanish Population

    Translational Vision Science and Technology, Vol. 11, Núm. 6

  2. Changes in the Epidemiology of Diabetic Retinopathy in Spain: A Systematic Review and Meta-Analysis

    Healthcare (Switzerland), Vol. 10, Núm. 7

  3. Guía de recomendaciones para el manejo de brolucizumab

    Archivos de la Sociedad Española de Oftalmologia, Vol. 97, Núm. 11, pp. 626-638

2021

  1. Rho-Kinase Inhibitors for the Treatment of Refractory Diabetic Macular Oedema

    Cells, Vol. 10, Núm. 7

  2. Role of intraretinal and subretinal fluid on clinical and anatomical outcomes in patients with neovascular age-related macular degeneration treated with bimonthly, treat-and-extend and as-needed ranibizumab in the In-Eye study

    Acta ophthalmologica, Vol. 99, Núm. 8, pp. 861-870

  3. Signature of circulating biomarkers in recurrent non-infectious anterior uveitis. Immunomodulatory effects of dha-triglyceride. a pilot study

    Diagnostics, Vol. 11, Núm. 4

2020

  1. A robust method for the automatic location of the optic disc and the fovea in fundus images

    Computer Methods and Programs in Biomedicine, Vol. 196

  2. Bimonthly, treat-and-extend and as-needed ranibizumab in naïve neovascular age-related macular degeneration patients: 12-month outcomes of a randomized study

    Acta Ophthalmologica, Vol. 98, Núm. 7, pp. e820-e829

  3. CHANGES IN TOTAL AND INNER RETINAL THICKNESSES IN TYPE 1 DIABETES WITH NO RETINOPATHY AFTER 8 YEARS OF FOLLOW-UP

    Retina (Philadelphia, Pa.), Vol. 40, Núm. 7, pp. 1379-1386

  4. Clinical and molecular-genetic insights into the role of oxidative stress in diabetic retinopathy: Antioxidant strategies and future avenues

    Antioxidants, Vol. 9, Núm. 11, pp. 1-19

  5. Detección automática de patología en imágenes de fondo de ojo utilizando técnicas de deep learning

    XXXVIII Congreso Anual de la Sociedad Española de Ingeniería Biomédica. CASEIB 2020: Libro de actas

  6. Effective fundus image decomposition for the detection of red lesions and hard exudates to aid in the diagnosis of diabetic retinopathy

    Sensors (Switzerland), Vol. 20, Núm. 22, pp. 1-17

  7. Interpretation of OCT and OCTA images from a histological approach: Clinical and experimental implications

    Progress in Retinal and Eye Research, Vol. 77

  8. Satisfaction of patients and primary care professionals with a teleophthalmology-based screening programme for diabetic retinopathy in a rural area in Castilla y León, Spain

    Rural and remote health, Vol. 20, Núm. 1, pp. 5180

2019

  1. Combination of global features for the automatic quality assessment of retinal images

    Entropy, Vol. 21, Núm. 3

  2. Entropy rate superpixel classification for automatic red lesion detection in fundus images

    Entropy, Vol. 21, Núm. 4

  3. Management and systemic implications of diabetic neovascular glaucoma

    Ophthalmic Research, Vol. 62, Núm. 2, pp. 111-115

  4. Management of diabetic macular edema patients in clinical practice in Spain

    European Journal of Ophthalmology, Vol. 29, Núm. 6, pp. 664-672